RNS Number : 8457P
e-Therapeutics plc
05 September 2017



("e-therapeutics" or the "Company")


Notification of Half Year Results Date


Oxford, UK - 5 September 2017 - e-therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its half year results for the six months ended 31 July 2017 on Tuesday, 26 September 2017.




For more information, please contact:


e-therapeutics plc

Ray Barlow, Chief Executive Officer

Steve Medlicott, Finance Director


Tel: +44 (0) 1993 883 125 


Numis Securities Limited

Michael Meade/Freddie Barnfield
(Corporate Finance)

James Black (Corporate Broking)


Tel: +44 (0) 207 260 1000


Instinctif Partners

Melanie Toyne Sewell/Alex Shaw

Tel: +44 (0) 207 457 2020








About e-therapeutics plc

We are an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.  

Our novel methodology and our Discovery Engine allow us to discover new and better drugs in a more efficient and effective way.

e-therapeutics is headquartered in Oxford. For more information about the Company please visit 


This information is provided by RNS
The company news service from the London Stock Exchange